e18813 Background: The City of Hope Center for Precision Medicine developed an enterprise-wide platform and precision medicine program to unlock the research potential and clinical value of complex and unique datasets by combining patient data with comprehensive genomic profiling and proprietary analytics. POSEIDON (Precision Oncology Software Environment Interoperable Data Ontologies Network) is a secure, cloud-based Oncology Insights Engine enabling exploration, analysis, visualization, and collaboration on our patient clinico-genomic data along with public data sources. This platform enables investigators to access and visualize data from clinical and multi-omics data and provides an engine that can be utilized for cohort discovery and exploration, preliminary feasibility testing to deriving patient specific insights based on real world data (RWD) and real-world evidence (RWE). Patients are consented through an IRB-approved protocol with active, opt-in participation. Methods: The POSEIDON Common Data Model (PCDM) is a standard, extensible data schema that incorporates patient data to support Precision Medicine. Data are incorporated from disparate data sources and stored in a combined harmonized manner promoting consistency of data and meaning across downstream applications. A multi-step process was created to capture and structure multiple data types into the PCDM. Natural language processing (NLP) tools are deployed to automate and structure valuable data elements from unstructured documents including pathology reports and clinical notes. NLP augmented software tools were developed to assist manual data abstractors to capture more complex terms and disease specific data elements which can include disease progression, progression free survival, and other outcomes. Results: Comprehensive data from 175,000 City of Hope patients are included within this environment for cohort exploration, longitudinal follow-up, outcomes, hypothesis development, and queries for synthetic controls. Data from disease specific-research registries constitute a rich dataset within POSEIDON by disease and tumor type, including lung cancer, colorectal cancer, breast cancer, leukemia, lymphoma and multiple myeloma, among other disease types. Automated genomic workflows were created to gain access to genomic profiling and whole exome sequencing. Genomic data is associated with the clinical data in the PCDM. Automated data flows from the Enterprise Data Warehouse EDW include data that is captured in discrete formats in the EDW and provided for in the PCDM and further enrich the data that flows from the disease registries. Statistically rigorous methods for de-identification are applied for collaborative studies. Conclusions: The City of Hope Center for Precision Medicine and the POSEIDON platform offer an exceptional resource for collaborative RWD & RWE studies.

To advance medicine toward better evidence-based, cost-effective and individualized treatment, a new model of discovery, translation and delivery of information must be developed. This requires the collaboration of the major constituents in the areas of healthcare (i.e., patients, clinicians, administrators and researchers) and the partnership of disciplines (i.e., bioinformatics, epidemiologists, statisticians, information technologists, physicians and scientists) and organizations (i.e., drug and device companies, healthcare agencies, academic and community medical centers and information technology firms) to develop an integrative platform. The over-riding goal of this platform is to improve patient care, with the developed system enabling this by providing each of the major constituents with evidence-based and tailored information at the individual patient level.